Wyniki wyszukiwania - Biblioteka Nauki

1

Inhibition of the receptor-mediated virion attachment to a lipid membrane

100%

Zhdanov V.

Open Physics

|

2012

|

tom 10

|

nr 5

1210-1215

EN

The forefront of the anti-viral defence is sometimes aimed at virion attachment to a host membrane. This step or, more specifically, virion contacts with cellular membrane receptors (or, e.g., glycolipids) can be inhibited by antibodies (or specially chosen or designed compounds) via their association with virions. In this case, the full-scale attachment of virions to a host membrane occurs via a subtle interplay of the formation and rupture of multiple virion-inhibitor and virion-receptor bonds. We present a kinetic model describing this interplay and illustrating general trends in the process under consideration.

2

Diagnosis EBV infection - methods, problems and interpretation of results

100%

Litwinska B. , Trzcinska A.

Bulletin of the Veterinary Institute in Puławy. Supplement

|

2002

3

Mikrobiologia a inżynieria sanitarna i inżynieria środowiska w kontekście pandemii COVID-19

86%

Gromiec M.

Gaz, Woda i Technika Sanitarna

|

2021

|

tom Nr 1-2

7--12

PL

W pracy przedstawiono znaczenie mikrobiologii w inżynierii sanitarnej i inżynierii środowiska, koronawirusy w kontekście pandemii i przyszłych chorób wirusowych.

EN

The paper presents a role of microbiology in sanitary and environmental engineering, coronaviruses in the context of COVID-19 and the future viral diseases.

4

Maria Morzycka. Professor of Medical University of Gdansk

86%

Morzycka-Palka M.

Acta Microbiologica Polonica

|

1994

|

tom 43

|

nr 3-4

5

Present status of classification of viruses of vertebrates

86%

Malicki K. , Toka F. N.

|

nr 5-6

6

HCMV infection - problems of laboratory diagnosis

86%

Siennicka J. , Zuk A. , Rechnio M. , Litwinska B.

Bulletin of the Veterinary Institute in Puławy. Supplement

|

2002

7

Differences in activation PBMC for interferon alpha production depending on the virulence of used herpes simplex virus type 1 strains

86%

Rehnio M. , Litwinska B.

Bulletin of the Veterinary Institute in Puławy. Supplement

|

2002

8

Studies on nuclear cytoplasmic polyhedrosis viruses of the satin moth (Stilpnotia salicis L.) (Lepidoptera, Lymantriidae)

72%

Ziemnicka J.

Prace Naukowe Instytutu Ochrony Roślin

|

1981

|

tom 23

|

nr 1

9

Purification, serology and some properties of two isolates of Pea enation mosaic virus

72%

Pospieszny H. , Paszkiewicz Z. , Pruszynska M.

Prace Naukowe Instytutu Ochrony Roślin

|

1983

|

tom 25

|

nr 2

10

The effectiveness of three conjugation methods of peroxidase with immunoglobulins used for the detection of broad bean stain virus in Elisa test

72%

Kaniewski W. , Jackowiak N.

Prace Naukowe Instytutu Ochrony Roślin

|

1985

|

tom 27

|

nr 2

11

European bat lyssaviruses — an ecological enigma

58%

Vos A. , Kaipf I. , Denzinger A. , Fooks A. R. , Johnson N. , Muller T.

Acta Chiropterologica

|

2007

|

tom 09

|

nr 1

EN

The first European case of bat rabies was reported in 1954. Since then, more than 800 cases have been confirmed from 13 countries. The causative agents are European Bat Lyssavirus Type-1 (EBLV-1) and Type-2 (EBLV-2). The natural host of EBLV-1 seems to be the serotine bat (Eptesicus serotinus) with more than 95% of all cases reported in this species. Although much fewer EBLV-2 cases have been identified, it seems that Myotis dasycneme and M. daubentonii are likely to be the principal hosts' species for this virus. The ecological mechanisms underlying the transmission of EBLV-1 and EBLV-2 are still poorly understood. In order to assess the public health risks associated with EBLVs and the implications for bat conservation, some issues need urgent clarification. In this review some of the most pressing topics will be addressed. Only collaboration between a range of disciplines that include virologists, epidemiologists and bat conservationists will be able to elucidate some of these unanswered questions.

12

Relationship between CMV infection and coronary heart disease

58%

Siennicka J. , Kruk M. , Przyluski J. , Krajewski P.

|

nr 2

13

Miroslaw Kantoch [1928-2007]

58%

|

nr 3

14

Use of HIV as a gene transfer vector

44%

Pluta K. , Kacprzak M. M.

Acta Biochimica Polonica

|

2009

|

tom 56

|

nr 4

531-595

EN

Despite the extensive research efforts over the past 25 years that have focused on HIV, there is still no cure for AIDS. However, tremendous progress in the understanding of the structure and biology of the HIV virus led to the development of safe and potent HIV-based transgene delivery vectors. These genetic vehicles are referred to as lentiviral vectors. They appear to be better suited for particular applications, such as transgene delivery into stem cells, compared to other viral- and non-viral vectors. This is because Lentivirus-based vectors can efficiently infect nondividing and slowly dividing cells. In the present review article, the current state of understanding of HIV-1 is discussed and the main characteristics that had an impact on vector design are outlined. A historical view on the vector concept is presented to facilitate discussion of recent results in vector engineering in a broader context. Subsequently, a state of the art overview concerning vector construction and vector production is given. This review also touches upon the subject of lentiviral vector safety and related topics that can be helpful in addressing this issue are discussed. Finally, examples of Lentivirus-based gene delivery systems and their applications are presented, with emphasis on animal transgenesis and human gene therapy.